返回 Agenda
Session 5, Track B: Driving Patient Safety Outcomes Through Communication and Stakeholder Alignment
Session Chair(s)
Josefina Mendoza
PV Alliance LATAM, Head of PV CAMEX, LRP-PV CAM. Global Drug Safety, Grünenthal LATAM, Panama
Juan Asbun, DRSc, MD
Pharmacovigilance and Patient Safety Regional Lead, Takeda México, S.A. De C.V., Mexico
This session will explore innovative strategies to enhance patient safety communication and stakeholder engagement within pharmacovigilance systems. It will address how to effectively communicate safety risks to special populations, including patients in home-administration programs. The session will also highlight the role of patient associations and alternative communication channels in improving risk awareness and reporting.
Learning Objective : - Identify at least three key strategies for communicating safety risks to special patient populations (e.g., rare diseases, home-administration)
- Evaluate the effectiveness of alternative communication channels (e.g., patient associations) in reaching and engaging these populations
- Design a tailored patient and caregiver engagement approach to support effective safety communication (e.g., rare diseases, home-administration)
Speaker(s)
Representative Invited
VP, Clinical Safety & Risk Management (CSRM) Therapeutics and Oncology, Moderna, United States
Speaker
Mariana Calzada
Country Safety/Pharmacovigilance Head, Opella Healthcare, Mexico
Speaker
Luis Ernesto Rozo, DrMed
President, Asociación Mexicana de Farmacovigilancia (AMFV), Mexico
Speaker